{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:37:17Z","timestamp":1784734637431,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12958-019-0477-8","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T14:03:47Z","timestamp":1554732227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum Antim\u00fcllerian hormone does not predict elevated progesterone levels among women who undergo controlled ovarian hyperstimulation for in vitro fertilization"],"prefix":"10.1186","volume":"17","author":[{"given":"Shahryar K.","family":"Kavoussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin L.","family":"Hunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady T.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John David","family":"Wininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keikhosrow M.","family":"Kavoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz K.","family":"Kavoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"3","key":"477_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0015-0282(97)80080-5","volume":"67","author":"F Ubaldi","year":"1997","unstructured":"Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997;67(3):521\u20136.","journal-title":"Fertil Steril"},{"issue":"6","key":"477_CR2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","volume":"80","author":"E Bosch","year":"2003","unstructured":"Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80(6):1444\u20139.","journal-title":"Fertil Steril"},{"issue":"11","key":"477_CR3","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1093\/humrep\/dew213","volume":"31","author":"B Lawrenz","year":"2016","unstructured":"Lawrenz B, Beligotti F, Engelmann N, Gates D, Fatemi HM. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod. 2016;31(11):2554\u201360.","journal-title":"Hum Reprod"},{"issue":"4","key":"477_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.rbmo.2012.01.010","volume":"24","author":"M Al-Azemi","year":"2012","unstructured":"Al-Azemi M, Kyrou D, Kolibianakis EM, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod BioMed Online. 2012;24(4):381\u20138.","journal-title":"Reprod BioMed Online"},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7827-9-29","volume":"9","author":"R Li","year":"2011","unstructured":"Li R, Qiao J, Wang L, et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol. 2011;9:29.","journal-title":"Reprod Biol Endocrinol"},{"key":"477_CR6","doi-asserted-by":"crossref","unstructured":"Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone\/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril. 2013;100(6):1622\u20138.e1\u20133.","DOI":"10.1016\/j.fertnstert.2013.08.045"},{"issue":"3","key":"477_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2174\/138920112799361927","volume":"13","author":"EM Kolibianakis","year":"2012","unstructured":"Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol. 2012;13(3):464\u201370 Review.","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"477_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/humupd\/dmt014","volume":"19","author":"CA Venetis","year":"2013","unstructured":"Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013;19(5):433\u201357.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"477_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370\u201385.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"477_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","volume":"85","author":"C Fi\u00e7icioglu","year":"2006","unstructured":"Fi\u00e7icioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006;85(3):592\u20136.","journal-title":"Fertil Steril"},{"issue":"5","key":"477_CR11","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","volume":"92","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Gelbaya TA, Wilkinson H, et al. Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92(5):1586\u201393.","journal-title":"Fertil Steril"},{"issue":"5","key":"477_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","volume":"14","author":"DN Lekamge","year":"2007","unstructured":"Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-M\u00fcllerian hormone as a predictor of IVF outcome. Reprod BioMed Online. 2007;14(5):602\u201310.","journal-title":"Reprod BioMed Online"},{"issue":"5","key":"477_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10815-013-9973-5","volume":"30","author":"WQ Lin","year":"2013","unstructured":"Lin WQ, Yao LN, Zhang DX, Zhang W, Yang XJ, Yu R. The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). J Assist Reprod Genet. 2013;30(5):649\u201355.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"477_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.rbmo.2012.02.027","volume":"26","author":"R Fleming","year":"2013","unstructured":"Fleming R, Broekmans F, Calhaz-Jorge C, et al. Can anti-M\u00fcllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reprod BioMed Online. 2013;26(5):431\u20139.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"477_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0300-595X(78)80010-3","volume":"7","author":"KP McNatty","year":"1978","unstructured":"McNatty KP. Cyclic changes in antral fluid hormone concentrations in humans. Clin Endocrinol Metab. 1978;7(3):577\u2013600.","journal-title":"Clin Endocrinol Metab"},{"issue":"3","key":"477_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/eem.13.15","volume":"8","author":"J Holte","year":"2013","unstructured":"Holte J, Brodin T. High levels of anti-M\u00fcllerian hormone: what does this mean for IVF treatment? Expert Review of Endocrinology & Metabolism. 2013;8(3):209\u201311.","journal-title":"Expert Review of Endocrinology & Metabolism"},{"key":"477_CR17","doi-asserted-by":"crossref","unstructured":"Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion.Fertil Steril. 2013;99(1):44\u20136.","DOI":"10.1016\/j.fertnstert.2012.09.038"},{"issue":"3","key":"477_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","volume":"77","author":"DB Seifer","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum m\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77(3):468\u201371.","journal-title":"Fertil Steril"},{"issue":"6","key":"477_CR19","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","volume":"99","author":"JC Arce","year":"2013","unstructured":"Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99(6):1644\u201353.","journal-title":"Fertil Steril"},{"issue":"1","key":"477_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/AOG.0b013e318278eeda","volume":"121","author":"MG Katz-Jaffe","year":"2013","unstructured":"Katz-Jaffe MG, Surrey ES, Minjarez DA, Gustofson RL, Stevens JM, Schoolcraft WB. Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol. 2013;121(1):71\u20137.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"477_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10815-011-9567-z","volume":"28","author":"S Lee","year":"2011","unstructured":"Lee S, Ozkavukcu S, Heytens E, Moy F, Alappat RM, Oktay K. Anti-Mullerian hormone and antral follicle count as predictors for embryo\/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone. J Assist Reprod Genet. 2011;28(7):651\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"477_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","volume":"150","author":"K Majumder","year":"2010","unstructured":"Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):166\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"477_CR23","first-page":"877","volume":"27","author":"L Kotanidis","year":"2013","unstructured":"Kotanidis L, Asimakopoulos B, Nikolettos N. Association between AMH, oocyte number and availability of embryos for cryopreservation in IVF. In Vivo. 2013;27(6):877\u201380.","journal-title":"In Vivo"},{"issue":"4","key":"477_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10815-014-0193-4","volume":"31","author":"P Lehmann","year":"2014","unstructured":"Lehmann P, V\u00e9lez MP, Saumet J, et al. Anti-M\u00fcllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet. 2014;31(4):493\u20138.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"477_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.fertnstert.2015.06.007","volume":"104","author":"SK Kavoussi","year":"2015","unstructured":"Kavoussi SK, Odenwald KC, Boehnlein LM, et al. Antim\u00fcllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng\/mL versus 1-4 ng\/mL. Fertil Steril. 2015;104(3):633\u20136.","journal-title":"Fertil Steril"},{"issue":"12","key":"477_CR26","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s40618-016-0521-x","volume":"39","author":"L Kotanidis","year":"2016","unstructured":"Kotanidis L, Nikolettos K, Petousis S, et al. The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF. J Endocrinol Investig. 2016;39(12):1459\u201364.","journal-title":"J Endocrinol Investig"},{"key":"477_CR27","doi-asserted-by":"crossref","unstructured":"Reichman DE, Goldschlag D, Rosenwaks Z. Value of antim\u00fcllerian hormone as a prognostic indicator of in vitro fertilization outcome. Fertil Steril. 2014;101(4):1012\u20138.e1.","DOI":"10.1016\/j.fertnstert.2013.12.039"},{"issue":"10","key":"477_CR28","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","volume":"30","author":"Z Merhi","year":"2013","unstructured":"Merhi Z, Zapantis A, Berger DS, Jindal SK. Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve. J Assist Reprod Genet. 2013;30(10):1361\u20135.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"477_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.rbmo.2012.11.018","volume":"26","author":"P Bhide","year":"2013","unstructured":"Bhide P, Gudi A, Shah A, Timms P, Grayson K, Homburg R. Anti-M\u00fcllerian hormone as a predictor of pregnancy following IVF. Reprod BioMed Online. 2013;26(3):247\u201352.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"477_CR30","first-page":"24","volume":"10","author":"M Goswami","year":"2017","unstructured":"Goswami M, Nikolaou D. Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF? J Hum Reprod Sci. 2017;10(1):24\u201330.","journal-title":"J Hum Reprod Sci"},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","volume":"225","author":"SSE Alson","year":"2018","unstructured":"Alson SSE, Bungum LJ, Giwercman A, Henic E. Anti-m\u00fcllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-m\u00fcllerian hormone is modest. Eur J Obstet Gynecol Reprod Biol. 2018;225:199\u2013204.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"477_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/humrep\/dev339","volume":"31","author":"C Blockeel","year":"2016","unstructured":"Blockeel C, Drakopoulos P, Santos-Ribeiro S, Polyzos NP, Tournaye H. A fresh look at the freeze-all protocol: a SWOT analysis. Hum Reprod. 2016 Mar;31(3):491\u20137.","journal-title":"Hum Reprod"},{"issue":"2","key":"477_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","volume":"378","author":"Y Shi","year":"2018","unstructured":"Shi Y, Sun Y, Hao C, et al. Transfer of Fresh versus Frozen Embryos in Ovulatory Women. N Engl J Med. 2018 Jan 11;378(2):126\u201336.","journal-title":"N Engl J Med"},{"issue":"2","key":"477_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5653\/cerm.2015.42.2.67","volume":"42","author":"JH Park","year":"2015","unstructured":"Park JH, Jee BC, Kim SH. Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles. Clin Exp Reprod Med. 2015;42(2):67\u201371.","journal-title":"Clin Exp Reprod Med"},{"issue":"3","key":"477_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/humrep\/14.3.601","volume":"14","author":"N Doldi","year":"1999","unstructured":"Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod. 1999 Mar;14(3):601\u20135.","journal-title":"Hum Reprod"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-019-0477-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-019-0477-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-019-0477-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T13:01:14Z","timestamp":1663246874000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-019-0477-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s12958-019-0477-8","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Since the dataset was de-identified, this study was granted IRB exemption by St David\u2019s Healthcare Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"35"}}